BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1857694)

  • 1. [Use of lysenyl-forte and methergoline in the therapy of hyperprolactinemic hypogonadism].
    Mel'nichenko GA; Dedov II; Gitel' EP; Ilovaĭskaia IA
    Probl Endokrinol (Mosk); 1991; 37(2):20-2. PubMed ID: 1857694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome].
    Balabolkin MI; Gerasimov GA; Snigireva RIa; Gorokhova TR
    Klin Med (Mosk); 1989 Sep; 67(9):89-92. PubMed ID: 2586051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperprolactinemic amenorrhea with Metergoline.
    Bohnet HG; Kato K; Wolf AS
    Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
    Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
    J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of using parlodel in hyperprolactinemia].
    Mel'nichenko GA; Gitel' EP; Romantsova TI
    Probl Endokrinol (Mosk); 1990; 36(3):29-33. PubMed ID: 2395828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
    Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B
    Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of lisuride in the treatment of hyperprolactinemic amenorrhea.
    Rojanasakul A; Sirimongkolkasem R; Chailurkit LO
    J Med Assoc Thai; 1990 Feb; 73 Suppl 1():42-6. PubMed ID: 2351912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinemia and hypogonadism.
    Vaidya RA
    J Assoc Physicians India; 1993 Nov; 41(11):700-1. PubMed ID: 8005920
    [No Abstract]   [Full Text] [Related]  

  • 12. Amenorrhea, galactorrhea, and hyperprolactinemia.
    Magyar DM
    J Am Osteopath Assoc; 1985 Jun; 85(6):375-80. PubMed ID: 3905728
    [No Abstract]   [Full Text] [Related]  

  • 13. Bilateral mastectomy for refractory galactorrhea.
    Simianu VV; Wiebke EA; Cacioppo JR; Kennedy PR
    Breast J; 2011; 17(5):558-60. PubMed ID: 21827562
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
    Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperprolactinemia. Its relation to galactorrhea, amenorrhea, pituitary tumor and its management.
    Ge QS; Xu L; Wang HL; Gu CX; Lin SQ; Xu YD; Yu KM; Xie YZ; Shi YF; Zang X
    Chin Med J (Engl); 1985 Aug; 98(8):543-50. PubMed ID: 3937678
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperprolactinemia. Study of a current topic].
    Cano López H
    Ginecol Obstet Mex; 1991 Dec; 59():362-6. PubMed ID: 1819544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.